During the past decade, East Bay Rheumatology Medical Group, Inc conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 21 clinical trials were completed, i.e. on average, 84% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 15 clinical trials were completed. i.e. 187.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East Bay Rheumatology Medical Group, Inc" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Horizon Therapeutics Ireland DAC" with 3 trials sponsored, "R-Pharm International, LLC" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "EMD Serono" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East Bay Rheumatology Medical Group, Inc" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "East Bay Rheumatology Medical Group, Inc" are "Rheumatoid Arthritis" (10 trials), "Systemic Lupus Erythematosus" (7 trials), "Lupus Erythematosus, Systemic" (6 trials), "Arthritis, Psoriatic" (2 trials) and "Arthritis, Rheumatoid" (2 trials). Many other conditions were trialed in "East Bay Rheumatology Medical Group, Inc" in a lesser frequency.

Most popular intervention types in "East Bay Rheumatology Medical Group, Inc" are "Drug" (29 trials), "Biological" (6 trials), "Other" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Atacicept 150 mg" (2 trials), "Baricitinib" (2 trials), "IPP-201101" (2 trials) and "Pegloticase" (2 trials). Other intervention names were less common.

The vast majority of trials in "East Bay Rheumatology Medical Group, Inc" are 33 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "East Bay Rheumatology Medical Group, Inc". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in East Bay Rheumatology Medical Group, Inc, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in East Bay Rheumatology Medical Group, Inc, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 0 trials that are defined as “Not Applicable".